1. Home
  2. NKTX vs CAAS Comparison

NKTX vs CAAS Comparison

Compare NKTX & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.09

Market Cap

132.8M

Sector

Health Care

ML Signal

HOLD

CAAS

China Automotive Systems Inc.

HOLD

Current Price

$4.48

Market Cap

130.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
CAAS
Founded
2015
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
132.8M
130.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
NKTX
CAAS
Price
$2.09
$4.48
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$13.25
N/A
AVG Volume (30 Days)
708.2K
22.7K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.68
EPS
N/A
1.11
Revenue
N/A
$725,260,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.00
Revenue Growth
N/A
16.72
52 Week Low
$1.31
$3.50
52 Week High
$2.74
$5.37

Technical Indicators

Market Signals
Indicator
NKTX
CAAS
Relative Strength Index (RSI) 69.68 58.36
Support Level $1.79 $4.24
Resistance Level $2.22 $4.60
Average True Range (ATR) 0.08 0.13
MACD 0.04 0.02
Stochastic Oscillator 75.73 61.84

Price Performance

Historical Comparison
NKTX
CAAS

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: